Search
for
Sort by
Research 30 of 1000+
- Dual-drug nanostructured lipid carriers of spironolactone and 2-deoxy-D-ribose for targeted follicular delivery in androgenetic alopecia
- Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women<sup>1</sup>
- New drug targets and research methods for androgenetic alopecia
- Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia.
- Advances in the Treatment of Androgenetic Alopecia: A Review of Mechanisms and the Clinical Efficacy of Combination Drug Therapy
- Can we halt male androgenetic alopecia progression without antiandrogenic drugs?
- Drugs and Androgenetic Alopecia: What to look out for
- Microneedling for Androgenetic Alopecia: A Synergistic Strategy Enhancing Drug Delivery and Follicular Regeneration
- Analysis on the treatment compliance of patients with androgenetic alopecia and its influencing factors: based on the comparison between microneedle therapy and drug therapy
- Innovative strategies for the discovery of new drugs against androgenetic alopecia
- An update on nanocarriers for follicular-targeted drug delivery for androgenetic alopecia topical treatment
- LB792 Minoxidil and dutasteride drug tattooing for male Androgenetic Alopecia
- Fractional‐assisted drug delivery performed with erbium yag laser in androgenic alopecia: Histological aspects
- Thyroid receptor β: A promising target for developing novel anti-androgenetic alopecia drugs
- New investigational drugs for androgenetic alopecia
- Drug development to improve androgenetic alopecia on the Traditional Chinese Medicine theory
- <i>In vitro</i> and <i>in vivo</i> models for androgenetic alopecia drug development
- Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma — with or without concurrent bimatoprost and/or minoxidil
- Expression of the L-Fucose Moiety on Infrainfundibular Follicular Keratinocytes of Terminal Follicles, Its Decreased Expression on Vellus and Indeterminate Follicles of Androgenetic Alopecia, and Re-Expression in Drug-Induced Hair Regrowth
- Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride
- Androgenetic alopecia treatment: associating 1550nm erbium-glass laser with drug injections of active principles
- Androgenetic alopecia; drug safety and therapeutic strategies
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Uncovering novel biomarkers and drug targets for androgenetic alopecia via metabolite regulation and multi-tissue validation
- Bicalutamide: A potential new oral anti-androgenic drug for female pattern hair loss - A case series
- Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia
- Response to the letter to the editor; Androgenetic alopecia; drug safety and therapeutic strategies
- Anti-Androgen Drugs in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
- Experimental and early investigational drugs for androgenetic alopecia
- A bibliometric analysis of alternative drug therapy options in the treatment of androgenetic alopecia